Newsroom - Page 9

What We’re Reading, July 13, 2016: Humira faces competition from a biosimilar; Washington, DC, campaigns to raise awareness on anti-HIV PrEP pills; and veterans may have been incorrectly diagnosed for traumatic brain injury...or not.
Promotional advertising by cancer centers has seen a dramatic spike in recent years, with 890 cancer centers spending $173 million for advertising in 2014.
What We're Reading, July 12, 2016: Oregon's Health CO-OP to close down by the end of July; experts discuss fairer ways to decide on drug pricing; and gender bias in physician salaries at academic institutions.
Researchers examined genetic information from 120,000 people from across the globe. The effort involved more than 300 scientists, including NIH's Francis Collins, MD, PhD.
Researchers assessed balugrastim’s efficacy, safety, and tolerability in 4 different clinical trials and found it to be a suitable alternative to pegfilgrastim in regard to reducing the mean duration of severe neutropenia.
The National Cancer Institute (NCI) estimates that the aging US population will contribute to a substantial increase in the number of older cancer survivors over the next 25 years.
The president predicts that in 20 years, the nation will look back on "Obamacare" as a moment of courage that has improved people's lives.
According to a study conducted in the United Kingdom, statins can reduce the risk of dying from breast, prostate, lung, and bowel cancer.
Diabetes Compendium
Oncology Compendium
Reimbursement Compendium
Know Your News
HF Compendium